APA

Kudahetti S. C., Fisher G., Ambroisine L., Prowse D., Kattan M. W., Foster C. S., Møller H., Oliver T., Fletcher A., Cooper C., Reuter V., Scardino P., Cuzick J. & Berney D. M. (20110103). Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. : Pathology.

Chicago

Kudahetti Sakunthala C, Fisher Gabrielle, Ambroisine Laurence, Prowse David, Kattan Michael W, Foster Christopher S, Møller Henrik, Oliver Tim, Fletcher Anne, Cooper Colin, Reuter Victor, Scardino Peter, Cuzick Jack and Berney Daniel M. 20110103. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. : Pathology.

Harvard

Kudahetti S. C., Fisher G., Ambroisine L., Prowse D., Kattan M. W., Foster C. S., Møller H., Oliver T., Fletcher A., Cooper C., Reuter V., Scardino P., Cuzick J. and Berney D. M. (20110103). Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. : Pathology.

MLA

Kudahetti Sakunthala C, Fisher Gabrielle, Ambroisine Laurence, Prowse David, Kattan Michael W, Foster Christopher S, Møller Henrik, Oliver Tim, Fletcher Anne, Cooper Colin, Reuter Victor, Scardino Peter, Cuzick Jack and Berney Daniel M. Immunohistochemistry for p16, but not Rb or p21, is an independent predictor of prognosis in conservatively treated, clinically localised prostate cancer. : Pathology. 20110103.